Clinical Trials By Condition
  1. Dermatomyositis
  2. Mycosis Fungoides
  3. Necrobiosis Lipoidica (NL)
  4. Neutrophilic Dermatoses
  5. Plaque Psoriasis
  6. Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
A Pilot, Phase 2, Randomized, Placebo-controlled, Double-blind, Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of a Thalidomide Derivative (CC-220) in Subjects with Systemic Lupus Erythematosus

If you are interested in posting your Clinical Trial on the Philadelphia Dermatological Society website, please Click Here to submit a request.